Recombinant EGFR (Zalutumumab Biosimilar) 抗体
Research Grade
适用: 人
ELISA
宿主: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all EGFR (Zalutumumab Biosimilar) products
- EGFR (Zalutumumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Mammalian Cells
- Expression System
- Mammalian cells
-
克隆类型
- 单克隆
-
标记
- This EGFR (Zalutumumab Biosimilar) antibody is un-conjugated
-
应用范围
- ELISA
- 原理
- Zalutumumab Biosimilar - Anti-EGFR mAb
- 产品特性
- Antibody Type: IgG1-kappa
- 纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
- 质量等级
- Research Grade
- 亚型
- IgG1 kappa
-
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS pH 7.5
- 储存条件
- -80 °C
- 储存方法
- store at -80°C
-
- 抗原
- EGFR (Zalutumumab Biosimilar)
- Abstract
- EGFR (Zalutumumab Biosimilar) 产品
- 别名
- ERBB antibody, ERBB1 antibody, HER1 antibody, PIG61 antibody, mENA antibody, epidermal growth factor receptor antibody, EGFR antibody
- 物质类
- Biosimilar
- 背景
-
HuMax-EGFr
Zalutumumab (proposed trade name HuMax-EGFR) is a high affinity, completely human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR, also known as ErbB1/HER1). It is developed by Genmab and designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. Zalutumumab is derived from transgenic mice immunized with A431-derived EGFR. - CAS-编号
- 667901-13-5
-
You are here:
